Osmotic delivery systems and piston assemblies for use therein

• US 7,879,028 B2
• Filed: 02/09/2010
• Issued: 02/01/2011
• Est. Priority Date: 08/09/2006
• Status: Active Grant

• Current Assignee: Intarcia Therapeutics, Inc.
• Original Assignee: Intarcia Therapeutics, Inc.
• Inventors: Zamora, Pauline C., Lautenbach, Scott D., DesJardin, Michael A., Lam, Stan, Alessi, Thomas R.
• Primary Examiner(s): Sirmons; Kevin C
• Assistant Examiner(s): Mehta; Bhisma
• Application Number:
  US12/658,570
• Publication Number:
  US 20100185184A1
• Time in Patent Office: 357 Days
• Field of Search: 604/891.1, 604/892.1, 604/218, 604/219, 604/221, 604/222
• US Class Current: 604/892.1
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61M 2005/14513 with secondary fluid driving or regulating the infusion
• CPC Class Codes: A61M 2205/0216 Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/14526 the piston being actuated by fluid pressure
• CPC Class Codes: F16J 9/26 characterised by the use of particular materials
• CPC Class Codes: F16J 9/28 of non-metals
• CPC Class Codes: Y10T 29/49826 Assembling or joining

Abstract

An osmotic delivery system is disclosed for delivering an active agent formulation to a fluid environment. The osmotic delivery system typically comprises a reservoir having a lumen that contains the active agent formulation and an osmotic agent formulation and a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation. The piston assembly typically comprises a body constructed and arranged for positioning in the lumen. The body is typically made of a polymeric material that is, for example, resistant to leaching in an organic solvent. In one embodiment, the body is a columnar body having a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and the piston assembly further comprises a spring retained at the distal end of the columnar body for biasing the rim of the columnar body against the wall of the reservoir.

Claims

1. A piston assembly for positioning in a lumen of a reservoir for an osmotic delivery system, comprising

a columnar body constructed and arranged for positioning in the lumen, wherein the columnar body has a core made of a polymeric material comprising an ultra high molecular weight polyethylene, the columnar body further comprising a rim at a distal end thereof for engaging and sealing against an interior wall of the reservoir and a spring retained at the distal end for biasing the rim against the interior wall of the reservoir.

2. The piston assembly of claim 1, wherein the spring is a radial spring.

3. The piston assembly of claim 2, wherein the spring is a canted coil spring.

4. The piston assembly of claim 1, wherein the spring is made of a non-reactive metal.

5. The piston assembly of claim 1, wherein the polymeric material produces volatile leachates of less than about 1.4 μ

g/ml when exposed to benzyl benzoate at 40°

C. for at least about 45 days.

6. An osmotic delivery system for delivering an active agent formulation to a fluid environment, comprising:

a reservoir, comprising an interior wall, that defines a lumen containing the active agent formulation and an osmotic agent formulation; and

the piston assembly of claim 1 positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation, wherein the piston assembly engages and seals against the interior wall of the reservoir.

7. The osmotic delivery system of claim 6, further comprising a semipermeable membrane positioned at a first end of the reservoir adjacent the osmotic agent formulation.

8. The osmotic delivery system of claim 7, further comprising a flow modulator positioned at a second end of the reservoir adjacent the active agent formulation, said flow modulator having an orifice for delivering the active agent formulation to the fluid environment.

9. The osmotic delivery system of claim 6, wherein the active agent formulation is a suspension formulation comprising a suspension vehicle comprising one or more organic solvent.

10. The osmotic delivery system of claim 9, wherein the suspension formulation further comprises a particle formulation comprising one or more polypeptide selected from the group consisting of interferons and insulinotropic peptides.

11. The osmotic delivery system of claim 10, wherein the polypeptide is selected from the group consisting of alpha interferon, beta interferon, delta interferon, gamma interferon, omega interferon, lambda interferon, tau interferon, interferon analog polypeptides, interferon derivative polypeptides, and mixtures thereof.

12. The osmotic delivery system of claim 10, wherein the polypeptide is selected from the group consisting of glucagon like protein 1 (GLP-1), GLP-1 derivative polypeptides and analog polypeptides, exendin-4, and exendin-4 derivative polypeptides and analog polypeptides.

13. A method of manufacturing the osmotic delivery system of claim 6, comprising

providing the reservoir, the active agent formulation, the osmotic agent formulation, the piston assembly, a semipermeable membrane and a flow modulator;

assembling the reservoir, the active agent formulation, the osmotic agent formulation, the piston assembly, the semipermeable membrane and the flow modulator, such that the piston assembly is positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation, the semipermeable membrane is positioned at a first end of the reservoir adjacent the osmotic agent formulation, and the flow modulator is positioned at a second end of the reservoir adjacent the active agent formulation.

15. The osmotic delivery device of claim 6, wherein the insulinotropic polypeptide is selected from the group consisting of glucagon like protein 1 (GLP-1), GLP-1 derivative polypeptides and analog polypeptides, exendin-4, and exendin-4 derivative polypeptides and analog polypeptides.

16. The osmotic delivery system of claim 15, wherein the insulinotropic polypeptide is exendin-4.

14. An osmotic delivery system for delivering an active agent formulation to a fluid environment, comprising:

a reservoir, comprising an interior wall, that defines a lumen containing the active agent formulation and an osmotic agent formulation;

the active agent formulation comprising

a suspension vehicle, the suspension vehicle comprising benzyl benzoate and polyvinylpyrrolidone, and

a particle formulation comprising an insulinotropic polypeptide;

a piston assembly positioned in the lumen of the reservoir, the piston assembly comprising

a columnar body having a core made of a polymeric material comprising an ultra high molecular weight polyethylene, the columnar body further comprising a rim at a distal end thereof for engaging and sealing against the interior wall of the reservoir and a spring retained at the distal end for biasing the rim against the interior wall of the reservoir, wherein the piston assembly isolates the active agent formulation from the osmotic agent formulation;

a semipermeable membrane positioned at a first end of the reservoir adjacent the osmotic agent formulation; and

a flow modulator positioned at a second end of the reservoir adjacent the active agent formulation, said flow modulator having an orifice for delivering the active agent formulation to the fluid environment.